Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy With Carboplatin and Paclitaxel for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)
Sponsor: National Cancer Institute (NCI)
A PHASE1/PHASE2 clinical study on Lung Adenocarcinoma and Lung Adenocarcinoma, Mixed Subtype, this trial is ongoing. The trial is conducted by National Cancer Institute (NCI) and has accumulated 70 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
70 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Dec 2025 — Mar 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Nov 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
▶ Show 65 earlier versions
-
May 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jan 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Nov 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2024 — May 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2024 — Feb 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2023 — Oct 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2022 — Mar 2023 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2021 — Mar 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2019 — Apr 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2017 — Jan 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Oct 2017 — Nov 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2017 — Oct 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2017 — Jul 2017 [monthly]
Recruiting PHASE1_PHASE2
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2017 — May 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .